Boston Family Office’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-72,929
| Closed | -$2.64M | – | 245 |
|
|
2016
Q4 | $2.64M | Sell |
72,929
-35,590
| -33% | -$1.29M | 0.34% | 87 |
|
|
2016
Q3 | $4.99M | Sell |
108,519
-1,530
| -1% | -$70.4K | 0.65% | 49 |
|
|
2016
Q2 | $5.53M | Hold |
110,049
| – | – | 0.72% | 45 |
|
|
2016
Q1 | $5.89M | Sell |
110,049
-242
| -0.2% | -$13K | 0.78% | 41 |
|
|
2015
Q4 | $7.24M | Sell |
110,291
-100
| -0.1% | -$6.56K | 0.99% | 30 |
|
|
2015
Q3 | $6.23M | Hold |
110,391
| – | – | 0.87% | 32 |
|
|
2015
Q2 | $6.52M | Sell |
110,391
-1,135
| -1% | -$67.1K | 0.82% | 35 |
|
|
2015
Q1 | $6.95M | Hold |
111,526
| – | – | 0.86% | 34 |
|
|
2014
Q4 | $6.41M | Hold |
111,526
| – | – | 0.8% | 37 |
|
|
2014
Q3 | $6M | Sell |
111,526
-76
| -0.1% | -$4.09K | 0.77% | 39 |
|
|
2014
Q2 | $5.85M | Sell |
111,602
-2,390
| -2% | -$125K | 0.74% | 42 |
|
|
2014
Q1 | $6.02M | Hold |
113,992
| – | – | 0.8% | 38 |
|
|
2013
Q4 | $4.57M | Sell |
113,992
-7,565
| -6% | -$303K | 0.6% | 56 |
|
|
2013
Q3 | $4.59M | Sell |
121,557
-6,570
| -5% | -$248K | 0.65% | 49 |
|
|
2013
Q2 | $5.02M | Buy |
+128,127
| New | +$5.02M | 0.76% | 41 |
|